14-day Premium Trial Subscription Try For FreeTry Free

64 Biggest Movers From Yesterday

09:26am, Friday, 22'nd May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 21) ADC Therapeutics SA (NYSE:...
At this time, I will turn the conference over to Bob Yedid with LifeSci Advisors. Good morning, this is Bob Yedid with LifeSci Advisors. Joining me from Kamada are Amir London, Chief Executive Offic
Kamada (KMDA) delivered earnings and revenue surprises of 62.50% and 8.17%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Recap: Kamada Q1 Earnings

11:18am, Monday, 18'th May 2020
Shares of Kamada (NASDAQ:KMDA) were flat in pre-market trading after the company reported Q1 results.Quarterly Results Earnings per share were unchanged 0.00% year over year to $0.12, which beat the e
Total Revenues were $33.3 Million, an Increase of 24% Year-over-YearNet Income was $5.2 Million, an Increase of 6% Year-over-YearCompany Reports Continued Progress of its.
Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived biopharmaceutical company, today announced that it will release financial results for the first quarter ended March 31, 2020, prior to the open of t
Kamada (KMDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE